BiotechTube
Home/Aurealis Therapeutics/Laurent Décory
LD

Laurent Décory

COO

Aurealis Therapeutics

Therapeutic Areas

Chronic WoundsOncologyInflammatory Diseases

Aurealis Therapeutics Pipeline

DrugIndicationPhase
AUP-16Chronic Diabetic Foot Ulcers (DFU)Phase 2
AUP-55Solid Tumors (Ovarian, Peritoneal, Bladder, Recurrent Melanoma)Pre-clinical/Phase 1

Leadership Team at Aurealis Therapeutics

JY
Juha Yrjänheikki
CEO
MP
Matleena Piiroinen
Drug Safety Officer
View full Aurealis Therapeutics profile